F-group (family)
2011.1.1.3 Peptidase_M17
Ligands and drugs
975
Member domains
458
with ligand contacts (≤ 4 Å)
47.0% of members
410
with DrugDomain annotations
42.1% of members
374
with a DrugBank compound
38.4% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 2011.1.1.3 belongs to X-group 2011 Phosphorylase/hydrolase-like, which binds 8.3 ligand superclasses per 20 proteins, broader than 62% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB03424 | BES | Ubenimex | 37 |
| DB07448 | BEY | (2S)-3-[(R)-[(1S)-1-amino-3-phenylpropyl](hydroxy)phosphoryl]-2-benzylpropanoic acid | 13 |
| DB04310 | BB2 | 2-[(Formyl-Hydroxy-Amino)-Methyl]-Heptanoic Acid [1-(2-Hydroxymethyl-Pyrrolidine-1-Carbonyl)-2-Methyl-Propyl]-Amide | 7 |
| DB01694 | TAR | D-tartaric acid | 6 |
| DB02386 | PLU | Leucine Phosphonic Acid | 3 |
| DB00149 | LEU | Leucine | 2 |
| DB08766 | ZED | Zofenoprilat | 2 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| ZNmetal | ZINC ION | 375 |
| MNmetal | MANGANESE (II) ION | 71 |
| NAmetal | SODIUM ION | 40 |
| BES | 2-(3-AMINO-2-HYDROXY-4-PHENYL-BUTYRYLAMINO)-4-METHYL-PENTANOIC ACID | 37 |
| CL | CHLORIDE ION | 28 |
| MGmetal | MAGNESIUM ION | 17 |
| Kmetal | POTASSIUM ION | 13 |
| 1OT | {(R)-amino[4-(1H-pyrazol-1-yl)phenyl]methyl}phosphonic acid | 12 |
| 3MW | 4-amino-N-{(1R)-2-(hydroxyamino)-2-oxo-1-[4-(1H-pyrazol-1-yl)phenyl]ethyl}benzamide | 12 |
| 4TK | N-[(1R)-1-(4-bromophenyl)-2-(hydroxyamino)-2-oxoethyl]-2,2-dimethylpropanamide | 12 |
| 4TL | N-[(1R)-2-(hydroxyamino)-2-oxo-1-(3',4',5'-trifluorobiphenyl-4-yl)ethyl]-2,2-dimethylpropanamide | 12 |
| 4TM | N-{(1R)-2-(hydroxyamino)-2-oxo-1-[4-(thiophen-3-yl)phenyl]ethyl}-2,2-dimethylpropanamide | 12 |
| 4TY | tert-butyl [(1R)-1-(4-bromophenyl)-2-(hydroxyamino)-2-oxoethyl]carbamate | 12 |
| 4U5 | N-{(1R)-2-(hydroxyamino)-1-[4-(1-methyl-1H-pyrazol-4-yl)phenyl]-2-oxoethyl}-2,2-dimethylpropanamide | 12 |
| 4U6 | N-{(1R)-2-(hydroxyamino)-1-[3'-(N'-hydroxycarbamimidoyl)biphenyl-4-yl]-2-oxoethyl}-2,2-dimethylpropanamide | 12 |
| 4ZN | (2S)-2-{[(R)-[(R)-amino(phenyl)methyl](hydroxy)phosphoryl]methyl}-4-methylpentanoic acid | 12 |
| 5IF | N-{(1R)-2-(hydroxyamino)-1-[4'-(hydroxymethyl)[1,1'-biphenyl]-4-yl]-2-oxoethyl}-2,2-dimethylpropanamide | 12 |
| BEY | (2S)-3-[(R)-[(1S)-1-amino-3-phenylpropyl](hydroxy)phosphoryl]-2-benzylpropanoic acid | 12 |
| DGZ | N-((2R,3S,6S,18S,21S)-2-amino-18-(4-benzoylbenzyl)-21-carbamoyl-3-hydroxy-6-(naphthalen-2-ylmethyl)-4,7,16,19-tetraoxo-1-phenyl-11,14-dioxa-5,8,17,20-tetraazapentacosan-25-yl)hex-5-ynamide | 12 |
| J1V | N-[(1R)-2-(hydroxyamino)-2-oxo-1-(3',4',5'-trifluoro[1,1'-biphenyl]-4-yl)ethyl]cyclohexanecarboxamide | 12 |